Dassault Systemes and Accelrys, announced the signing of a definitive merger agreement under which Dassault will acquire the San Diego-based company. Under the terms of the agreement, Dassault will make an all-cash tender offer for all of the outstanding shares of Accelrys common stock at a price of $12.50 per share, without interest, representing a fully diluted equity value for Accelrys of approximately $750 million.
Dassault intends to acquire any shares of Accelrys not tendered into the tender offer, via a merger that will be effected as soon as possible after the closing of the tender offer.
According to the company, combining with Accelrys will "enrich the molecular chemistry capabilities from discovery to manufacturing and regulatory requirements of Dassault Systemes' formulation-based industry offerings such as life sciences, consumer packaged goods, high tech and energy, as well as advanced manufacturing industries."
"With Max Carnecchia and his teams, we share the same passion for enabling scientific innovation and are confident that together, leveraging the great Accelrys assets, we will deliver a unique and unmatched scientific PLM solution," said Bernard Charles, president and CEO, Dassault. "The world demands a new paradigm for sustainability where chemistry, materials and biology meet. This is what the virtual universes enabled by Dassault Systemes are delivering, capable of harmonizing products, nature and life, from imagination to industry solution experience."
The Board of Directors of Accelrys has unanimously approved the transaction, which is expected to be completed during the second quarter of 2014.
For more information, visit Dassault Systemes and Accelrys.
Sources: Press materials received from the company and additional information gleaned from the company's website.